In Vitro Maturation of Immature Oocytes

The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Polycystic Ovary Syndrome Adnexal Diseases Cysts Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Gonadal Disorders Neoplasms Ovarian Cysts Ovarian Diseases Ovarian Hyperstimulation Syndrome Urogenital Diseases

Age range

20 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IVF Unit, Shea Medical Center, Tel-Hashomer

Ramat Gan, 52621, Israel

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women with PCOS
Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
Women diagnosed with cancer who are interested in fertility preservation
Women with repeated IVF failure

Exclusion criteria

Severe cases of endometriosis
Large myomas
Hydrosalpinxs Technical problem with previous oocytes pick-up

Treatment and study plan

In Vitro Maturation of immature oocytes

Procedure

Sponsors and collaborators

Lead sponsor

Sheba Medical Center

Other Gov

Registry information

Important dates

First posted: May 30, 2007
Registry last updated: Dec 17, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed